By Cancer Research UK on 19th May 2020

Cancer Research UK’s Patient Information Services

Cancer Research UK’s patient information services can help people affected by cancer, despite the coronavirus crisis. All the information on CRUK’s ‘About cancer’ website comes direct from the experts –…

Read article
By Pinkie Chambers on 15th May 2020

The Centre for Medicines Optimisation, Research and Education

The Centre for Medicines Optimisation, Research and Education was initiated at UCL/UCLH to provide an infrastructure to help practising pharmacists conduct more research. Within Cancer this has benefited researchers from…

Read article
By BOPA Committee on 12th May 2020

BOPA Winter Survey Results Report 2019

Please see the BOPA 2019 Winter Survey Results HERE

Read article
By BOPA Committee on 12th May 2020

BOPA Executive Committee Minutes – February 2020 

Please see minutes for the February BOPA Executive TCON HERE

Read article
By BOPA Committee on 12th May 2020

BOPA Executive Committee Minutes – January 2020

Please see minutes for the January BOPA Executive TCON HERE

Read article
By Alia Nizam on 1st May 2020

National SACT regimen-specific consent forms – Publication update ‘Guidance on remote consent’

  In response to the COVID-19 pandemic the guidance with three potential scenarios for remote consent is now available. On behalf of the  SACT consent form national steering group, the…

Read article
By Steve Williamson on 30th April 2020

NHSE Interim treatment options

Message from Steve Williamson, NHS England Lead Cancer Pharmacist 29th April 2020 – NHSE Interim treatment options   Dear Colleague You may have seen that NICE has published an updated…

Read article
By Rob Duncombe - BOPA Treasurer on 22nd April 2020

ISOPP Conference

BOPA is please to inform our membership that the ISOPP 2019 conference generated a surplus. In line with HMRC guidance this surplus will be classed as restricted funds and will…

Read article
By MOGA on 9th April 2020

MOGA (the Medical Oncology Group of Australia): Practical considerations for the management of cancer patients during the COVID19 pandemic

Please find the pre-print of the Segelov paper which has been endorsed by MOGA (the Medical Oncology Group of Australia) and is awaiting publication. Click here

Read article
By Netty Cracknell on 8th April 2020

BOPA Guidance on the contents of a SACT protocol

A guide for members on what information is recommended to be included in a SACT protocol.   Available here: https://www.bopa.org.uk/resources/bopa-guidance-on-contents-of-sact-protocol/ 

Read article
By Netty Cracknell on 8th April 2020

BOPA Cancer Pharmacy Education and Training Standards

This programme has been developed to ensure that there is a baseline standard for training for all pharmacy staff within the UK who verify SACT prescriptions or discuss treatment with…

Read article
By [email protected] on 7th April 2020

National generic immunotherapy consent form

The consent form project team is pleased to announce that the national generic immunotherapy consent form has been reviewed and is now available on the CRUK website at: www.cruk.org/sact_consent. The…

Read article